Yingqiu Qi

2.2k total citations · 2 hit papers
34 papers, 1.9k citations indexed

About

Yingqiu Qi is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Yingqiu Qi has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Biomedical Engineering and 11 papers in Molecular Biology. Recurrent topics in Yingqiu Qi's work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (6 papers) and Peptidase Inhibition and Analysis (6 papers). Yingqiu Qi is often cited by papers focused on Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (6 papers) and Peptidase Inhibition and Analysis (6 papers). Yingqiu Qi collaborates with scholars based in China, Australia and United States. Yingqiu Qi's co-authors include Guangjun Nie, Yinlong Zhang, Xuexiang Han, Huan Min, Xiao Zhao, Keman Cheng, Yiye Li, Yao Li, Ying Xu and Ying Zhao and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Yingqiu Qi

31 papers receiving 1.9k citations

Hit Papers

Bioengineered bacteria-derived outer membrane vesicles as... 2019 2026 2021 2023 2021 2019 100 200 300

Peers

Yingqiu Qi
En Ren China
Hao Qin China
Hang Liu China
Yujing Li China
Peng Lv China
Yingqiu Qi
Citations per year, relative to Yingqiu Qi Yingqiu Qi (= 1×) peers Guangna Liu

Countries citing papers authored by Yingqiu Qi

Since Specialization
Citations

This map shows the geographic impact of Yingqiu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqiu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqiu Qi more than expected).

Fields of papers citing papers by Yingqiu Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingqiu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqiu Qi. The network helps show where Yingqiu Qi may publish in the future.

Co-authorship network of co-authors of Yingqiu Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yingqiu Qi. A scholar is included among the top collaborators of Yingqiu Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqiu Qi. Yingqiu Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bian, et al.. (2025). The pan-cancer analysis of LRG1 and its potential role in kidney renal clear cell carcinoma. RSC Medicinal Chemistry. 16(4). 1781–1796.
2.
Zhang, Jingjuan, Yongzheng Li, Furong Zhu, et al.. (2025). PROTAC based targeted degradation of LRG1 for mitigating corneal neovascularization. Journal of Controlled Release. 381. 113567–113567. 2 indexed citations
3.
Zhang, Jingjuan, Shiyu Song, Miao Xie, et al.. (2025). Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: Progress and perspectives. Materials Today Bio. 33. 102051–102051.
4.
Du, Lin, Huan Min, Yana Zhang, et al.. (2025). LRG1-Targeted Camptothecin Nanomicelles with Simultaneous Delivery of Olaparib for Enhanced Colorectal Cancer Chemotherapy. Nano Letters. 25(8). 3130–3140.
5.
Qi, Yingqiu, Yana Zhang, Hanqing Chen, et al.. (2025). Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 Degradation. ACS Nano. 19(28). 25645–25661. 2 indexed citations
6.
Qi, Yingqiu, Xi Yang, Yana Zhang, et al.. (2024). Targeted degradation of LRG1 to attenuate renal fibrosis. Asian Journal of Pharmaceutical Sciences. 19(4). 100941–100941. 8 indexed citations
7.
Zhu, Furong, Tao Huang, Shengnan Du, et al.. (2023). Identification of LRG1 targeting peptide and its application in targeted imaging for breast cancer. Nano Research. 17(10). 9044–9051. 7 indexed citations
8.
Huang, Tao, Xiaofan Sun, Yingqiu Qi, et al.. (2023). Immunogenic cell death effects induced by doxorubicin improved chemo-immunotherapy via restoration of granzyme B activity. Nano Research. 16(12). 13250–13258. 10 indexed citations
9.
Qi, Yingqiu, Chen Liu, Hui Wang, et al.. (2023). Modularly designed peptide-based nanomedicine inhibits angiogenesis to enhance chemotherapy for post-surgical recurrence of esophageal squamous cell carcinomas. Nano Research. 16(5). 7347–7354. 5 indexed citations
10.
Qi, Yingqiu, Hui Wang, Chen Liu, et al.. (2022). Engineering Multifunctional Thylakoid as an Oxygen Self-Supplying Photosensitizer for Esophageal Squamous Cell Carcinoma-Targeted Photodynamic Therapy. CCS Chemistry. 5(11). 2519–2533. 9 indexed citations
11.
Huang, Tao, Xianfu Sun, Yapeng Li, et al.. (2022). Peptide self-assembled nanomedicine induces antitumor immunity by blocking the PD-1/PD-L1 axis. Frontiers in Materials. 9. 2 indexed citations
12.
Zhang, Ruijuan, et al.. (2021). Self‐assembled peptide hydrogel scaffolds with VEGF and BMP‐2 enhanced in vitro angiogenesis and osteogenesis. Oral Diseases. 28(3). 723–733. 22 indexed citations
13.
Cheng, Keman, Ruifang Zhao, Yao Li, et al.. (2021). Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nature Communications. 12(1). 2041–2041. 359 indexed citations breakdown →
14.
Taleb, Mohammad, Yazhou Wang, Hamideh Rezvani Alanagh, et al.. (2021). Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition. Advanced Healthcare Materials. 10(12). e2100051–e2100051. 31 indexed citations
15.
Min, Huan, Jing Wang, Yingqiu Qi, et al.. (2019). Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy. Advanced Materials. 31(15). e1808200–e1808200. 356 indexed citations breakdown →
16.
Chen, Lixia, et al.. (2019). Application of Peptide-Based Nanoformulations for Targeting and Regulating Tumor Microenvironment. 32(5). 567–581. 2 indexed citations
17.
Xu, Jiaqi, Yinlong Zhang, Junchao Xu, et al.. (2019). Reversing tumor stemness via orally targeted nanoparticles achieves efficient colon cancer treatment. Biomaterials. 216. 119247–119247. 51 indexed citations
18.
Lang, Jiayan, Xiao Zhao, Yingqiu Qi, et al.. (2019). Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Associated Fibroblast Inactivation with Peptide-Assembly-Based Nanosystem. ACS Nano. 13(11). 12357–12371. 139 indexed citations
19.
Xu, Ying, Xuexiang Han, Yiye Li, et al.. (2019). Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity. ACS Nano. 13(11). 13445–13455. 131 indexed citations
20.
Zhang, Yinlong, Jingyan Wei, Shaoli Liu, et al.. (2017). Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis. Theranostics. 7(5). 1062–1071. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026